Werfen

Werfen

The Werfen team has completed a major competitive conversion in North America, at CommonSpirit Health. As the second largest health system in the US, CommonSpirit comprises 142 hospitals across 21 states. 

We are pleased to announce that we have recently obtained the CE (Conformité Européenne) mark for the Aptiva® Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) reagents.

Digital solutions are quite often downgraded to secondary status, not recognized as primary products but rather as ancillary components buried within the overall solution.

In February, the EEMEA ACDx Team completed a 2-day Launch Training for the new Acute Care Diagnostics solutions at the Werfen Learning Center in Dubai. 

In 2024 Werfen EEMEA has launched its first Digital Campaign, as a detailed and phased approach, to enhance its digital presence and strengthen partnerships with customers on HemoHub – Intelligent Data Manager.

In a significant achievement, Werfen & AFMS has recently marked a great victory in a coagulation tender for Sulaiman Habib Group, the largest private hospital chain in the Kingdom of Saudi Arabia.

Eastern Europe and Baltics Kick-Off 2024 event, which took place in Budapest from January 29th to 31st, was a great success. The event's motto, "We are One” – “Motivated and Healthy Team”, truly encapsulated the spirit of unity that was present throughout the 2-day event.

Werfen is committed to help raise awareness on issues that impede appropriate patient care. On March 8th and for International Women’s Day, we raise awareness to #InspireInclusion by inspiring action that help women and girls make informed decisions about their health.

The awesome Emporda region in Spain hosted the “We are One” EEMEA 2024 Kick Off Meeting: the team, 53 people from Milan, Dubai, Barcelona and Dreiech gathered in a wonderful seafront location to attend a 3-day event, from 16th to 19th of January, of business reviews, HR updates and Marketing and Customer Support Call to Actions.

Dear Valued Partner, 

As we embark on a new year filled with promise and opportunities, we are thrilled to extend a warm welcome to each and every one of you to the first edition of our quarterly Good Morning EEMEA!

First and foremost, we are excited to remember that our Werfen family has expanded significantly with the recent acquisition of Immucor, announced last year, bringing onboard new colleagues, Partners and opportunities! This is a testament to our continued growth and commitment to delivering innovative solutions in healthcare. We extend a heartfelt welcome to our new colleagues and Partners and look forward to the exciting collaborations and achievements that lie ahead as we unite under the Werfen banner: We are one!

Page 17 of 41

 

All rights reserved. © werfen.com

Get in touch

with the EEMEA team:

eemea@werfen.com

 

werfenplain

Issues

Go to top